Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Description Next-Generation Metabolic & Weight Management Research Peptide Retatrutide is an investigational triple-agonist peptide designed to activate three key metabolic pathways: GLP-1 (Glucagon-Like Peptide-1) , GIP (Glucose-Dependent Insulinotropic Polypeptide) , and glucagon receptors
We thank the support of all staffs from the Wuhan National Biosafety Level 3 Laboratory of Wuhan Institute of Virology, CAS
This approach aligns with how the body responds to treatment while maximising long-term health benefits
Providers and patients must navigate which benefit a therapy will fall under
US$ 21.60
US$ 28.16
US$ 28.24
US$ 27.15
US$ 24.30
US$ 22.15
US$ 24.75
US$ 27.08
US$ 25.66
